Why the study?
Does chemical shift and dynamic gadolinium-enhanced MR imaging accurately differentiate adrenal adenomas from nonadenomas?
Does chemical shift and dynamic gadolinium-enhanced MR imaging accurately differentiate adrenal adenomas from nonadenomas?
Chemical shift MR imaging can accurately characterize adrenal adenomas with high specificity by visually comparing opposed-phase with in-phase GRE images.
Answers are grounded in this paper and cite their sources.
Supports visual chemical shift MRI for high-specificity adrenal adenoma characterization; leaves open prospective validation in broader cohorts.
PURPOSE: To assess the potential role of chemical shift and dynamic gadolinium-enhanced magnetic resonance (MR) imaging in the characterization of adrenal masses. MATERIALS AND METHODS: Fifty-one adrenal masses (35 adenomas and 16 nonadenomas) in 43 patients were evaluated with chemical shift MR imaging, dynamic gadolinium-enhanced MR imaging, or both. The relative change in the signal intensity (SI) ratio of the adrenal mass to liver and paraspinal muscles was quantitatively and qualitatively assessed. Opposed-phase gradient-echo (GRE) images were compared with in-phase images. RESULTS: With qualitative visual inspection, only adenomas showed a decrease in relative SI ratio on opposed-phase chemical shift images (specificity, 100%; sensitivity, 81%). Quantitative ratios corresponding to 100% specificity were also observed, with similar sensitivities. Adenomas could not be differentiated from nonadenomas with visual assessment of maximum SI after contrast material administration or washout. CONCLUSION: Characterization of an adrenal mass as an adenoma can be made with high specificity and acceptable sensitivity by visually comparing opposed-phase with in-phase GRE images.
No takes yet. Share an insight, caveat, or question.
Korobkin et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: